IMPACCT: mHealth 2018 is a unique dedicated forum where industry and clinical leaders can delve into clinical transformation in the making.

Providing fresh insights into how leading pharmaceutical companies and clinical research organizations are actually transforming clinical trials with mobile and digital technology, IMPACCT: mHealth looks beyond the theory or future promises, to focus specifically on real-world examples and learnings that will help drive the implementation of mHealth and digital tools in clinical programs, and overcome key operational, regulatory and strategic challenges.

Along with over 90+ senior level experts from large pharma, innovative biotech, pioneering academia and expert solution providers, this meeting will enable you to discover how they are accelerating clinical R&D, promoting patient-centricity and advancing the use of patient-facing data.

How is mHealth and digital actually changing the way clinical trials are planned, run and delivered today?

 What has changed, and what will change around how mobile technology can disrupt the traditional clinical R&D model?

These are the questions to be explored and answered in this collaborative discussion. You’ll be able to hear the latest case-studies in this space, and explore in full the applications and limitations of mobile and digital innovation in the context of clinical programs – with exclusive insights from organizations such as Pfizer, Novartis, CTTI, Duke-Margolis Center for Health Policy, Takeda, AbbVie, The Michael J. Fox Foundation, UCB, Eli Lilly or GSK.

These are exciting times for everyone actively involved in the efforts to bring the use of mHealth technologies in clinical research to the next level!